Skip to main content

Advertisement

SpringerLink
Log in

CAR T cells targeting solid tumors: carcinoembryonic antigen (CEA) proves to be a safe target

  • Letter to the Editors
  • Published:
Cancer Immunology, Immunotherapy Aims and scope Submit manuscript

The Original Article was published on 28 June 2017

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Thistlethwaite FC, Gilham DE, Guest RD et al (2017) The clinical efficacy of first-generation carcinoembryonic antigen (CEACAM5)-specific CAR T cells is limited by poor persistence and transient pre-conditioning-dependent respiratory toxicity. Cancer Immunol Immunother. doi:10.1007/s00262-017-2034-7

    PubMed  Google Scholar 

  2. Zhang C, Wang Z, Yang Z et al (2017) Phase I escalating-dose trial of CAR-T therapy targeting CEA(+) metastatic colorectal cancers. Mol Ther 25(5):1248–1258. doi:10.1016/j.ymthe.2017.03.010

    Article  CAS  PubMed  Google Scholar 

  3. Katz SC, Burga RA, McCormack E et al (2015) Phase I hepatic immunotherapy for metastases study of intra-arterial chimeric antigen receptor-modified T-cell therapy for CEA+ liver metastases. Clin Cancer Res 21(14):3149–3159. doi:10.1158/1078-0432.CCR-14-1421

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Parkhurst MR, Yang JC, Langan RC et al (2011) T cells targeting carcinoembryonic antigen can mediate regression of metastatic colorectal cancer but induce severe transient colitis. Mol Ther 19(3):620–626. doi:10.1038/mt.2010.272

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Center for Molecular Medicine Cologne, University of Cologne, Robert-Koch-Str. 21, 50931, Cologne, Germany

    Astrid Holzinger & Hinrich Abken

  2. Clinic I Internal Medicine, University Hospital Cologne, Robert-Koch-Str. 21, 50931, Cologne, Germany

    Astrid Holzinger & Hinrich Abken

Authors
  1. Astrid Holzinger
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hinrich Abken
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hinrich Abken.

Ethics declarations

Conflict of interest

All authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Holzinger, A., Abken, H. CAR T cells targeting solid tumors: carcinoembryonic antigen (CEA) proves to be a safe target. Cancer Immunol Immunother 66, 1505–1507 (2017). https://doi.org/10.1007/s00262-017-2045-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00262-017-2045-4

Search

Navigation